Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2019-08-12 9:35 pm Unchanged | 13D | Melinta Therapeutics Inc. MLNT | Vatera Healthcare Partners LLC | 12,780,731 55.1% | 0 (Unchanged) | View |
2019-07-10 2:58 pm Sale | 13G | MELINTA THERAPEUTICS INC. MLNT | FMR LLC | 0 0% | -2,873,764![]() (Position Closed) | View |
2019-07-02 5:15 pm Purchase | 13D | Melinta Therapeutics Inc. MLNT | Vatera Healthcare Partners LLC | 12,780,731 60.2% | 84,141![]() (+0.66%) | View |
2019-02-26 5:16 pm Sale | 13D | Melinta Therapeutics Inc. MLNT | Vatera Healthcare Partners LLC | 12,696,590 61.7% | -3,911,369![]() (-23.55%) | View |
2019-02-13 4:18 pm Sale | 13G | Melinta Therapeutics Inc. MLNT | Stonepine Capital Management LLC | 0 0% | -3,474,761![]() (Position Closed) | View |
2019-02-13 11:58 am Sale | 13G | Melinta Therapeutics Inc. MLNT | FMR LLC | 2,873,764 5.129% | -265,498![]() (-8.46%) | View |
2019-01-16 3:21 pm Sale | 13G | Melinta Therapeutics Inc. MLNT | Flynn James E | 4,126,770 4.985% | -2,793,944![]() (-40.37%) | View |
2019-01-03 5:20 pm Purchase | 13D | Melinta Therapeutics Inc. MLNT | Vatera Healthcare Partners LLC | 16,607,959 29.6% | 16,607,959![]() (New Position) | View |
2018-12-20 5:22 pm Unchanged | 13D | Melinta Therapeutics Inc. MLNT | OIKOS HOLDINGS LLC | 16,607,959 29.6% | 0 (Unchanged) | View |
2018-11-21 4:40 pm Unchanged | 13D | Melinta Therapeutics Inc. MLNT | OIKOS HOLDINGS LLC | 16,607,959 29.6% | 0 (Unchanged) | View |
2018-11-08 4:31 pm Unchanged | 13D | Melinta Therapeutics Inc. MLNT | OIKOS HOLDINGS LLC | 16,607,959 29.6% | 0 (Unchanged) | View |
2018-11-02 5:10 pm Purchase | 13G | Melinta Therapeutics Inc. MLNT | Stonepine Capital Management LLC | 3,474,761 6.2% | 3,474,761![]() (New Position) | View |
2018-09-10 10:02 am Sale | 13G | Melinta Therapeutics Inc. MLNT | FMR LLC | 3,139,262 5.604% | -3,150,247![]() (-50.09%) | View |
2018-06-11 09:59 am Purchase | 13G | Melinta Therapeutics Inc. MLNT | FMR LLC | 6,289,509 11.229% | 5,300,000![]() (+535.62%) | View |
2018-05-31 5:08 pm Purchase | 13D | Melinta Therapeutics Inc. MLNT | OIKOS HOLDINGS LLC | 16,607,959 29.7% | 7,878,500![]() (+90.25%) | View |